CR8324A - Uso de tigeciclina sola o en combinacion con rifampicina para tratar la osteomelitis y/o la artritis septica - Google Patents

Uso de tigeciclina sola o en combinacion con rifampicina para tratar la osteomelitis y/o la artritis septica

Info

Publication number
CR8324A
CR8324A CR8324A CR8324A CR8324A CR 8324 A CR8324 A CR 8324A CR 8324 A CR8324 A CR 8324A CR 8324 A CR8324 A CR 8324A CR 8324 A CR8324 A CR 8324A
Authority
CR
Costa Rica
Prior art keywords
joint
infection
combination
infections
bone
Prior art date
Application number
CR8324A
Other languages
English (en)
Spanish (es)
Inventor
Thomas Testa Raymond
Calhoun Jason
T Mader Jon
Original Assignee
Wyeth Corp
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp, Univ Texas filed Critical Wyeth Corp
Publication of CR8324A publication Critical patent/CR8324A/es

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
CR8324A 2003-09-05 2006-04-04 Uso de tigeciclina sola o en combinacion con rifampicina para tratar la osteomelitis y/o la artritis septica CR8324A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50047403P 2003-09-05 2003-09-05

Publications (1)

Publication Number Publication Date
CR8324A true CR8324A (es) 2008-08-26

Family

ID=40257280

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8324A CR8324A (es) 2003-09-05 2006-04-04 Uso de tigeciclina sola o en combinacion con rifampicina para tratar la osteomelitis y/o la artritis septica

Country Status (8)

Country Link
AR (1) AR045586A1 (zh)
CR (1) CR8324A (zh)
GT (1) GT200400176A (zh)
MY (1) MY140519A (zh)
PA (1) PA8611301A1 (zh)
PE (1) PE20050946A1 (zh)
TW (1) TW200518741A (zh)
ZA (1) ZA200602769B (zh)

Also Published As

Publication number Publication date
GT200400176A (es) 2005-10-03
MY140519A (en) 2009-12-31
PA8611301A1 (es) 2005-03-28
ZA200602769B (en) 2007-09-26
TW200518741A (en) 2005-06-16
PE20050946A1 (es) 2005-11-25
AR045586A1 (es) 2005-11-02

Similar Documents

Publication Publication Date Title
CO5690590A2 (es) Uso de tigeciclina sola o en combinacion con rifampicina para tratar la osteomielitis y/o la artritis septica
ATE248616T1 (de) Bioabsorbierbare arzneimittelabgabevorrichtung
ECSP077182A (es) Metodos para el tratamiento de infecciones endobronquiales
CY1113264T1 (el) Συνδυασμοι στροντιου για την προφυλαξη/θεραπεια των παθησεων των χονδρων ή/και των οστων
ECSP066805A (es) Compuestos silinano como inhibidores de cisteína proteasa
DOP2006000052A (es) Alargar el tiempo hasta la progresión de la enfermedad o la supervivencia de los pacientes de cáncer
AR037109A1 (es) Uso de flibanserina
GT200500113A (es) Derivados de pirimidina para tratar el crecimiento celular anomalo
ES2194784T3 (es) Procedimiento y dispositivo para el tratamiento de cuerpos despues de su fracturacion.
DOP2001000233A (es) Compuestos farmacéuticos
SV2004001417A (es) Composiciones famaceuticas y procedimientos para administrar agonistas selectivos del receptor ep2 ref. pc10465
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
ECSP034635A (es) Uso de compuestos del 1-fenil-3-dimetilaminopropano para el tratamiento de la incontinencia urinaria
CR8324A (es) Uso de tigeciclina sola o en combinacion con rifampicina para tratar la osteomelitis y/o la artritis septica
CR9691A (es) Inhibidores de 6-alquilideno-peneme b-lactama biciclicos y combinacion antibiotica de b-lactama: un antibiotico de amplio espectro
WO2003075654A3 (en) Treatment of surfaces populated by bacteria with a lucilia sericata extract
BR0307085A (pt) Terapia combinada para o tratamento de infecções bacterianas
BR0208654A (pt) Composições veterinárias compreendendo derivados de avermectina-oxima e praziquantel
ECSP034632A (es) Uso de compuestos del 6-dimetilaminometil-1-fenil-ciclohexaco sustituido en la terapia de la incontinencia urinaria
ES2218407T3 (es) Uso de oxazolidinonas tiamida para el tratamiento de la resorcion osea y la osteoporosis.
TW200738235A (en) Tricyclic 6-alkylidene-penem β-lactamase inhibitors and β-lactam antibiotic combination: a broad spectrum antibiotic
DK1439840T3 (da) Antibakterielle monobactam-forbindelser og fremgangsmåder til anvendelse heraf
GT200100099A (es) Derivados de higromicina a.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)